Day One Biopharmaceuticals, Inc.
DAWN
$9.73
$0.748.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.73M | -30.32M | -36.00M | -65.71M | 37.04M |
| Total Depreciation and Amortization | 934.00K | 964.00K | 894.00K | 759.00K | 746.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.44M | 6.82M | 8.61M | 8.21M | 65.18M |
| Change in Net Operating Assets | 7.55M | -2.27M | -32.51M | 26.74M | -52.21M |
| Cash from Operations | -5.81M | -24.81M | -59.00M | -30.01M | 50.75M |
| Capital Expenditure | 0.00 | -3.00K | -317.00K | -1.42M | -724.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 32.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.46M | 26.29M | -32.30M | -268.22M | -66.98M |
| Cash from Investing | 13.46M | 26.32M | -32.61M | -269.64M | -67.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 748.00K | -- | 1.85M | 179.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 20.94M |
| Cash from Financing | 0.00 | 748.00K | -- | 1.85M | 200.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.66M | 2.26M | -91.61M | -297.80M | 183.15M |